Italia markets closed

TRxADE HEALTH, Inc. (MEDS)

NasdaqCM - NasdaqCM Prezzo differito. Valuta in USD.
Aggiungi a watchlist
6,59+0,27 (+4,35%)
Alla chiusura: 04:00PM EDT
6,30 -0,29 (-4,47%)
Dopo ore: 05:02PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente6,32
Aperto6,50
Denaro0,00 x 0
Domanda0,00 x 0
Min-Max giorno6,50 - 6,59
Intervallo di 52 settimane3,69 - 44,56
Volume2.134
Media Volume30.353
Capitalizzazione9,275M
Beta (mensile su 5 anni)2,11
Rapporto PE (ttm)N/D
EPS (ttm)-17,96
Prossima data utili17 giu 2024 - 19 giu 2024
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendo25 mar 2024
Stima target 1AN/D
  • GlobeNewswire

    Superlatus Announces Distribution Partnership with North America's Leading Wholesale Distributor and Expanded Points of Retail Sales

    TAMPA, FL, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Superlatus, Inc. (“Superlatus”), a food technology and distribution company and wholly owned subsidiary of TRxADE HEALTH, Inc. (NASDAQ: MEDS, “TRxADE”), a pharmaceutical exchange platform provider, is pleased to announce that its subsidiary, Superlatus PD Holding Company, has entered into a supplier agreement with Rainforest Distribution Corp. (“Rainforest”), a leading Consumer Packaged Goods distributor serving over 3,000 retailers across 15 states i

  • GlobeNewswire

    Superlatus, Newly Merged with TRxADE HEALTH, Acquires the assets of Spero Foods, a plant-based tech company Disrupting the Dairy and Egg Industry.

    Spero is another addition to the growing Superlatus CPG portfolio under their Urgent Company umbrella of brands.Spero® is a plant-based tech company specializing in alternative dairy and egg replacements, on a mission to outcompete traditional dairy and egg products in scale, price, taste, and nutrition by utilizing internationally patent-pending technologies that transforms low-cost, sustainable, and scalable ingredients into plant-based alternatives. Spero’s mission is to scale mainstream dair

  • GlobeNewswire

    Superlatus Announces Planned Expansion into Pet Food Market

    TAMPA, FL, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Superlatus, Inc., a food technology and distribution company that recently merged with a subsidiary of pharmaceutical exchange platform provider TRxADE HEALTH, Inc. (Nasdaq: MEDS), today announced it plans to enter the worldwide pet foods market, specializing in plant-based, high-protein foods and snacks. Superlatus will launch the expansion with assorted flavors of baked plant-based treats, then intends to follow with a full offering of veterinarian